Viracta Therapeutics, Inc.

 Viracta Therapeutics, Inc. contact information is shown below
Owner:VIRACTA THERAPEUTICS, INC.
Owner Address:2533 S. Coast Highway 101, Suite 210 Cardiff CA 92007
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byViracta Therapeutics, Inc.

Brand:

VIRACTA

Description:

pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer;

Category: PHARMACEUTICAL THERAPEUTIC PREPARATIONS
Brand:

VIRACTA

Description:

pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer; pharmaceutical preparations for the treatment of cancer, tumors, and hematological malignancies;

Category: PHARMACEUTICAL THERAPEUTIC PREPARATIONS
Brand:

VIRACTA

Description:

The mark consists of stylized word VIRACTA.;Pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases and disorders; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer; pharmaceutical preparations for the treatment of cancer, tumors, and hematological malignancies;The color(s) teal and green is/are claimed as a feature of the mark.;Providing medical information, consultancy and advisory services; providing a website via a global computer network featuring information in the fields of cancer, viral-associated cancers and other viral associated diseases and disorders;Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical drug development services; research relating to medicines; medical research; pharmaceutical research and development services; medical research services in the field of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of biological and chemical preparations for the treatment of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of pharmaceutical products, preparations and compounds for the treatment of viral-associated cancers and other viral associated diseases and disorders; conducting clinical trials; conducting clinical trial regarding pharmaceutical preparations and drugs in the field of viral-associated cancers and other viral associated diseases and disorders; DNA screening and analysis services for scientific research purposes; research and development of pharmaceutical products, preparations and compounds for T-cell adoptive transfer, immune reconstitution, and cell-based immunotherapy; research and development of pharmaceutical products, preparations and compounds for the treatment of cancer, tumors, and hematological malignancies;

Category: